This inventor holds 1 USPTO granted patent. Top assignee: Laboratoires Serono S.a.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Louise Duerr-Myers: Innovator in Infertility Treatment
Introduction
Louise Duerr-Myers is a notable inventor based in Lausanne, Switzerland. She has made significant contributions to the field of medicine, particularly in the treatment of infertility in women. Her innovative approach utilizes biological agents derived from fish to enhance fertility treatments.
Latest Patents
Louise Duerr-Myers holds a patent for the "Use of fish for treating infertility." This invention relates to the use of FSH and/or a biologically-active analogue thereof in the production of a medicament aimed at treating infertility in women. The medicament is designed for administration at an initial dose ranging from 100 to 600 IU, followed by a second dose at least three days later during the stimulation phase. In one embodiment, the medicament is administered at a dose of 300 to 600 IU every third day for the first six days of the stimulation phase. Another embodiment specifies an initial dose of 100 to 500 IU, with the second dose given between three and six days after the initial dose.
Career Highlights
Louise Duerr-Myers is associated with Laboratoires Serono S.A., a company known for its focus on reproductive health and infertility treatments. Her work has been instrumental in advancing medical practices in this area, showcasing her dedication to improving women's health.
Collaborations
One of her notable collaborators is Ernest Loumaye, who has worked alongside her in the development of innovative treatments for infertility.
Conclusion
Louise Duerr-Myers exemplifies the spirit of innovation in the medical field, particularly in addressing infertility challenges. Her contributions through her patent and collaboration with esteemed colleagues continue to impact women's health positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile